PP
SWTX

PDT Partners’s SpringWorks Therapeutics SWTX Stock Holding History

PDT Partners’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50,387
Closed -$1.31M – 713
2022
Q4 		$1.31M Sell
50,387
-21,160
-30% -$521K 0.21% 166
2022
Q3 		$2.04M Sell
71,547
-17,235
-19% -$494K 0.31% 65
2022
Q2 		$2.19M Buy
+88,782
New +$3.25M 0.19% 153
2022
Q1 		– Sell
-33,500
Closed -$2.08M – 1106
2021
Q4 		$2.08M Buy
33,500
+24,896
+289% +$1.65M 0.16% 226
2021
Q3 		$546K Buy
+8,604
New +$663K 0.04% 458

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return